FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

22155011000001108: Tafamidis meglumine 20mg capsules (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Apr 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1480381000001119 Tafamidis meglumine 20mg capsules en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1480391000001117 Tafamidis meglumine 20mg capsules (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tafamidis meglumine 20mg capsules Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route capsule.oral ontology form and route true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules Is a Tafamidis true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules Has specific active ingredient Tafamidis meglumine true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules Is a Tafamidis false Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules Has specific active ingredient Tafamidis false Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules Has specific active ingredient Tafamidis false Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules Is a Product containing tafamidis false Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules Has active ingredient Tafamidis false Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vyndaqel 20mg capsules (Pfizer Ltd) Is a True Tafamidis meglumine 20mg capsules Inferred relationship Existential restriction modifier
Tafamidis meglumine 20mg capsules 30 capsule Has VMP True Tafamidis meglumine 20mg capsules Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start